Imaging plays a central role in evaluating responses to therapy in neuro-oncology patients.
The advancing clinical use of immunotherapies has demonstrated that treatment-related …

Recognizing and Minimizing Artifacts at CT, MRI, US, and Molecular Imaging | RadioGraphics
RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All Journals …

The American College of Radiology (ACR) and American College of Nuclear Medicine (ACNM)
collaborated to develop a clinical practice document for the performance of fluciclovine …

Primary malignancies of the head and neck are initially evaluated by physical examination
and direct visualization, such as endoscopy. 1–4 Physical examination is often accompanied …

With PET/MRI, the strengths of PET and MRI are combined to allow simultaneous image
acquisition and near-perfect image coregistration. MRI is increasingly being used for staging …

… Jonathan McConathy is an investigator in studies funded by NIH, Eli Lilly/Avid, Blue Earth
Diagnostics, Cytosite Biopharma, and ImaginAb. He is a consultant for Eli Lilly/Avid, GE …

Off-target binding of [ 18 F]flortaucipir (FTP) can complicate quantitative PET analyses. An
underdiscussed off-target region is the skull. Here, we characterize how often FTP skull …

[ 89 Zr]Oxinate 4 is a Positron Emission Tomography (PET) tracer for cell radiolabeling that
can enable imaging techniques to help better understand cell trafficking in various diseases. …

Background: African Americans are at increased risk for Alzheimer’s disease (AD) but
barriers to optimal clinical care are unclear. Objective: To comprehensively evaluate potential …

Background MRI alone has limited accuracy for delineating tumor margins and poorly
predicts the aggressiveness of gliomas, especially when tumors do not enhance. This study …